<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>牛津疫苗有效率为70％，在2剂治疗方案中进行的测试表明，该疫苗可能达到90％Oxford vaccine is 70% effective & tests on 2-dose regime show it could be 90%</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Oxford vaccine is 70% effective & tests on 2-dose regime show it could be 90%<br/>牛津疫苗有效率为70％，在2剂治疗方案中进行的测试表明，该疫苗可能达到90％</h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-11-23 15:45:22</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/11/eb92dad3837ed745de4edd204dbaaef7.jpg"><img src="http://img2.diglog.com/img/2020/11/eb92dad3837ed745de4edd204dbaaef7.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about the trial, please visit the  Oxford COVID-19 vaccine web hub or visit the   COVID-19 trial website .</p><p>我们的疫苗工作进展迅速。为确保您拥有最新信息或了解有关该试验的更多信息，请访问牛津COVID-19疫苗网络中心或访问COVID-19试验网站。</p><p> Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens</p><p> 包括131个Covid-19病例在内的3期中期分析表明，结合两种给药方案的数据后，该疫苗有效率为70.4％</p><p> In the two different dose regimens vaccine efficacy was 90% in one and 62% in the other</p><p> 在两种不同的剂量方案中，一种疫苗的效力为90％，另一种为62％</p><p>  Early indication that vaccine could reduce virus transmission from an observed reduction in asymptomatic infections</p><p>  早期迹象表明疫苗可通过观察到的无症状感染减少来减少病毒传播</p><p>  Large safety database from over 24,000 volunteers from clinical trials in the UK, Brazil and South Africa, with follow up since April</p><p>  来自英国，巴西和南非的24,000多名来自临床试验的志愿者的大型安全数据库，自4月以来一直在跟踪</p><p> Crucially, vaccine can be easily administered in existing healthcare systems, stored at ‘fridge temperature’ (2-8 °C) and distributed using existing logistics</p><p> 至关重要的是，疫苗可以在现有的医疗系统中轻松管理，存储在“冰箱温度”（2-8°C）中并使用现有的物流进行分发</p><p> Professor Andrew Pollard, Director of the Oxford Vaccine Group and Chief Investigator of the Oxford Vaccine Trial, said:</p><p> 牛津疫苗小组主任，牛津疫苗试验首席研究员安德鲁·波拉德教授说：</p><p> ‘These findings show that we have an effective vaccine that will save many lives. Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regimen is used, more people could be vaccinated with planned vaccine supply. Today’s announcement is only possible thanks to the many volunteers in our trial, and the hard working and talented team of researchers based around the world.’</p><p>‘这些发现表明，我们拥有一种可以拯救许多生命的有效疫苗。令人兴奋的是，我们发现我们的一种给药方案可能有90％左右有效，如果使用这种给药方案，则可以为更多的人接种计划中的疫苗。今天的宣布只有通过我们的试验中的许多志愿者以及遍布全球的辛勤工作和才华横溢的研究人员团队才有可能。’</p><p>  ‘The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by SARS-CoV-2. We will continue to work to provide the detailed information to regulators. It has been a privilege to be part of this multi-national effort which will reap benefits for the whole world.’</p><p>  ‘今天的宣布使我们更加接近可以使用疫苗来终结SARS-CoV-2造成的破坏的时代。我们将继续努力向监管机构提供详细信息。能够参与这项跨国努力，这将是举世无双的荣幸，这是我的荣幸。’</p><p>  Following the trial reaching the target for interim analysis, the independent Data and Safety Monitoring Board (DSMB) recommended that the team at Oxford conduct its first analysis on all the cases with data locked on 4 November 2020.</p><p>  在试验达到中期分析的目标后，独立的数据和安全监控委员会（DSMB）建议牛津团队对所有案件进行首次分析，并锁定数据于2020年11月4日。</p><p> These preliminary data indicate that the vaccine is 70.4% effective, with tests on two different dose regimens showing that the vaccine was 90% effective if administered at a half dose and then at a full dose, or 62% effective if administered in two full doses.</p><p> 这些初步数据表明该疫苗有效率为70.4％，对两种不同剂量方案的测试表明，如果先半剂量然后再全剂量给药，疫苗有效率为90％;如果两次全剂量给药，疫苗有效率为62％ 。</p><p> Additional cases are expected to accrue by the time of the final analysis and future analyses will determine the duration of protection. No serious safety events related to the vaccine have been identified.</p><p> 预计在最终分析之时还会有更多案件发生，未来的分析将确定保护的期限。尚未发现与疫苗相关的严重安全事件。</p><p> Oxford will now support AstraZeneca in submitting both the interim Phase III efficacy data and the extensive safety data to all regulators across the world, including in the UK, Europe and Brazil for independent scrutiny and product approval, including for emergency use. Many of these regulators have been reviewing the trial data on a rolling basis during the trial.</p><p> 牛津大学现在将支持阿斯利康向全球所有监管机构（包括英国，欧洲和巴西）提交中期III期中期疗效数据和广泛的安全性数据，以进行独立审查和产品批准，包括用于紧急用途。在审判期间，许多监管机构一直在滚动审查审判数据。</p><p> In parallel, Oxford is submitting the full analysis of the Phase III interim data for independent scientific peer review and publication. The coordination of the programme and execution of the trials in the UK would not have been possible without the support of the National Institute for Health Research and UKRI.</p><p> 同时，牛津大学将提交第三阶段中期数据的完整分析，以进行独立的科学同行评审和发表。没有国家卫生研究所和UKRI的支持，就不可能在英国进行计划的协调和试验的执行。</p><p> These data also suggest that this half dose and full dose regimen could help to prevent transmission of the virus, evidenced by lower rates of asymptomatic infection in the vaccinees, with further information to become available when trial data are next evaluated.</p><p>这些数据还表明，这种半剂量和全剂量方案可以帮助预防病毒的传播，这可通过疫苗中无症状感染率降低来证明，并在下次评估试验数据时可获得更多信息。</p><p> The interim Phase III data builds on  Oxford’s phase I/II peer-reviewed trial results which have shown that the vaccine induces strong antibody and T cell immune responses across all age groups, including older adults, and has a good safety profile.</p><p> III期中期数据基于牛津大学I / II期同行评审的试验结果得出，该结果表明，该疫苗在包括老年人在内的所有年龄段均能诱导强烈的抗体和T细胞免疫应答，并具有良好的安全性。</p><p> The clinical trials, enrolling over 24,000 participants from diverse racial and geographical groups in the UK, Brazil and South Africa, will now continue to final analysis. Further trials are being conducted in the United States, Kenya, Japan and India and the trial team expect to have under 60,000 participants by the end of the year. These trials will provide regulators with further information about the efficacy and safety of the Oxford candidate vaccine, including its ability to both protect against and stop the transmission of COVID-19.</p><p> 目前，该临床试验吸引了来自英国，巴西和南非的不同种族和地理地区的24,000多名参与者，现在将继续进行最终分析。在美国，肯尼亚，日本和印度正在进行进一步的试验，试验团队预计到今年年底将有不到60,000名参与者。这些试验将为监管机构提供有关牛津候选疫苗功效和安全性的更多信息，包括其预防和阻止COVID-19传播的能力。</p><p> The Oxford vaccine (ChAdOx1 nCoV-19) is made from a virus, which is a weakened version of a common cold virus (adenovirus), that has been genetically changed so that it is impossible for it to grow in humans.</p><p> 牛津疫苗（ChAdOx1 nCoV-19）由一种普通的感冒病毒（腺病毒）的弱化版本的病毒制成，这种病毒已经过基因改造，因此不可能在人体内生长。</p><p> Adenovirus vaccines have been researched and used extensively for decades and have the significant benefit that they are stable, easily manufactured, transported and stored at domestic fridge temperature (2-8 degrees C). This means they can be easily distributed using existing medical facilities such as doctor’s surgeries and local pharmacies, allowing for the vaccine, if approved, to be deployed very rapidly.</p><p> 腺病毒疫苗已被广泛研究和使用了数十年，其显着优势是可以在家用冰箱温度（2-8摄氏度）下稳定，易于制造，运输和存储。这意味着可以使用现有的医疗设施（例如医生的手术室和当地药房）轻松分发这些疫苗，从而使疫苗（如果获得批准）可以非常迅速地部署。</p><p> Oxford University’s collaboration with AstraZeneca has been crucial to the successful development of the vaccine and vital for its global manufacturing and distribution across the world. AstraZeneca already has international agreements in place to supply three billion doses of the vaccine, with access being built through more than 30 supply agreements and partner networks.</p><p> 牛津大学与阿斯利康的合作对于疫苗的成功开发至关重要，对于其在全球的生产和分销至关重要。阿斯利康已经制定了国际协议，以提供30亿剂疫苗，并通过30多个供应协议和合作伙伴网络建立联系。</p><p> A key element of Oxford’s partnership with AstraZeneca is the joint commitment to provide the vaccine on a not-for-profit basis for the duration of the pandemic across the world, and in perpetuity to low- and middle-income countries.</p><p> 牛津与阿斯利康的合作伙伴关系的一个关键要素是共同承诺，在全球大流行期间以及在中低收入国家/地区永久提供非营利性疫苗。</p><p>  ‘This is a great day for the University of Oxford and for universities everywhere. Pushing at the frontiers of knowledge with partners across the globe and putting our extraordinary brainpower in service to society, is what we do best.’</p><p>‘对于牛津大学和世界各地的大学来说，今天都是美好的一天。我们最擅长的是与全球合作伙伴一起开拓知识前沿，将我们非凡的才智服务于社会。”</p><p>  ‘Today marks an important milestone in our fight against the pandemic. This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency. Furthermore, the vaccine’s simple supply chain and our no-profit pledge and commitment to broad, equitable and timely access means it will be affordable and globally available supplying hundreds of millions of doses on approval.’</p><p>  ‘今天标志着我们与大流行作斗争的重要里程碑。这种疫苗的功效和安全性证实，它将对COVID-19非常有效，并将对这种突发公共卫生事件产生直接影响。此外，该疫苗的简单供应链以及我们对广泛，公平和及时获得疫苗的非营利承诺和承诺，这意味着该疫苗将是负担得起的，并且在全球范围内可提供，经批准可提供数亿剂。”</p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine">https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/tests/">#tests</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>